INTRODUCTION
In 2006, the World Health Organization reported approximately 9.2 million cases of active tuberculosis with 1.7 million deaths worldwide per year. Among the 85,000 cases of tuberculosis currently reported to the surveillance system in Brazil, nearly 8% are coinfected with human immunodeficiency virus (HIV) (1) (2) (3) . In Brazil, an average of 600,000 individuals is presently infected with HIV, which comprises one of the main risk factors for the progression from a latent tuberculosis infection to the active disease (1, (4) (5) (6) (7) .
Persons recently infected with Mycobacterium tuberculosis have a 3 to 5% chance to develop the disease in the first two years and 5 to 15% during their lifetime (8) . Most infected people remain healthy with a latent infection, demanding several immune mechanisms to prevent the disease progression (3, 9, 10) . Tuberculosis cases result from the evolution of a latent reactivated focus or from a recent exogenous infection.
Latent infection affects one third of the world population and the possibility of a latent reactivation focus in HIV-infected people, without intervention, may reach 10% every year (11, 12) . Tuberculosis lies among the major causes of opportunistic diseases in HIV-infected patients, leading to high lethality (1, 4, 9, 13) .
The identification of latent tuberculosis infection makes possible the adoption of strategies to lower its morbidity and mortality rates in HIV/AIDS patients (4, (13) (14) (15) (16) .
Even presenting limitations, the tuberculin skin test (TST) is the most commonly used infection-detection method and should be performed in all HIV-infected individuals at the time of diagnosis and annually, if the first result is negative (16) . In asymptomatic HIV-positive patients an induration equal to or greater than 5 mm is a positive result (6, 8, 17) . After a positive diagnosis, the patients should receive isoniazid chemoprophylaxis. The risk of reactivation of latent tuberculosis is believed to increase up to 100-fold when compared with HIV negative individuals, whereas the development of the active disease in the HIV/AIDS population may have an incidence of 1.7 to 7.9 per 100 persons per year (15, 18) .
The objective of the present study was to investigate latent tuberculosis infection using the tuberculin skin test (TST) in patients assisted at the university hospital in Campo Grande, Mato Grosso do Sul, Brazil, to compose the latent tuberculosis scenario in the midwest of Brazil. De Oliveira SMVL et 
PATIENTS AND METHODS

Patients
This is a cross-section descriptive study with quantitative approach. The HIV/AIDS population was selected from the Day-Care Hospital Prof. Esterina Corsini, at the Federal University of Mato Grosso do Sul (UFMS), Campo Grande, Brazil, in 2008.
The sample size was calculated considering the prevalence of tuberculosis infection estimated in 15% (±6%), based on studies carried out with the HIV/AIDS population; significance level 5% (19) (20) . Thus, the minimal sample size to meet the aim of this study was 108 adult patients, a non-probabilistic sample of HIV/AIDS patients treated during June through December, 2008.
Ethical Aspects
The project was approved by the Ethical Committee of UFMS (protocol 1060). All volunteers signed a document of informed consent.
Data Collection
All participants were asked to answer a questionnaire on sociodemographic variables 
RESULTS
Of the 492 HIV/AIDS patients clinically followed at the Day-Care Hospital Prof.
Esterina Corsini, 108 were consecutively included from June to December 2008.
Among the studied individuals, 53.70% (58) were females; 76.85% (83) were aged between 20 and 49 years, and in 62.96% (66) the formal education level ranged from 0 to 10 years of schooling.
Latent tuberculosis infection was identified in 13.9% of the HIV/AIDS patients, of whom 66.76% (10) were female and 73.3% were aged between 20 and 49 years.
There was no statistical difference between the TST-positive HIV/AIDS patients and the TST-negative persons regarding sex, age, schooling, familiar income, smoking habit and alcohol abuse (screened through the CAGE questionnaire) as shown in 
variables, CD4+ T cell count was significantly associated, at 10% level, with positive tuberculin test. In the negative tuberculin reaction group, the median value of CD4+ T cells was 390 cells/mm 3 , whereas in the TST positive group this count (average) was 626 cells/mm 3 (p-value = 0.091). It was also observed that among persons who reacted negatively, the median value of CD8+ T was higher than among those with positive TST (p-value = 0.026) and about twice as high as CD4+ T in the same group (Table 2 ).
The diagnosis time showed to be considerably associated with TST positivity (pvalue = 0.01), with a median diagnosis time of eight years, whereas among TSTnegative patients, this period was four years ( Table 2 ).
The group of TST positive individuals in use of antiretroviral therapy did not present any statistical difference. Eighty-two and 41% HIV/AIDS patients were under highly active antiretroviral treatment.
The viral load revealed a significant association (p-value = 0.046) when compared with the TST-positivity variable. A higher level of viral load was observed in TSTnegative individuals. In those who reacted positively, 80% (12/15) had undetectable viral RNA load (log ≤ 50 copies/mL), as displayed in 
DISCUSSION
The prevalence of tuberculosis infection in Latin America is well documented and affects about 30% of the general population (13) . In Europe and North America, although the prevalence of tuberculosis is lower, the reemergence of this disease has been well described, due to HIV/AIDS pandemics afflicting especially immigrants from Latin American countries and vulnerable populations (refugees, healthcare professionals, inmates and drugs addicts), who are more exposed to tuberculosis infection and disease (4, (21) (22) (23) (24) (25) . Brazilian studies indicate a 20 to 50% prevalence of tuberculosis infection in susceptible persons such as healthcare professionals (25) .
The increase of tuberculosis and HIV/AIDS coinfection rates has given rise to serious implications for tuberculosis control programs due to the augmentation of cases and elevated mortality rates in the coinfected population (13, 24) . Several studies carried out in Latin American countries demonstrated that tuberculosis infection rates in HIV/AIDS population range from 0 to 25% (15, 20, 22, 26, 27) . The present study found a 13.9% prevalence of tuberculosis infection in the HIV/AIDS population.
The connection between the number of lymphocytes CD4+ T per cubic millimeter and the skin response to PPD remains unclear in the literature (16, 28 ). In the current study, no significant association between tuberculin positive individuals and CD4+T lymphocyte count was found. In the population who tested negative for tuberculin, the median value of CD4+ T cells showed to be significantly lower, as previously reported by other researchers (16, 20) .
Several studies reported that most HIV-infected individuals do not respond to the skin test with PPD, thus showing a statistical relation with a low CD4+T cell count (20) . On the other hand, other works did not find any connection between TST positivity and induration higher than 5 mm or higher absolute counting of CD4+T cells (16) .
Moreover, anergy is soundly related to low CD4+T cell count (20) . Some authors found 10 to 80% anergy in HIV/AIDS populations (20, 26 ).
In the current study, it is worth noting that any participant with positive tuberculin test had CD4+T cell count lower than 200/mm 3 . In the literature, low CD4+T cell count is associated with negative tuberculin test (20, 26, 27) . However, monitoring alone is not sufficient for the tuberculosis control; thus, isoniazid preventive therapy is highly recommended (15, 18) .
Since numerous patients affected by HIV/AIDS infection were non-reactive to TST, probably due to alterations in cellular immune response caused by the virus, it is possible that, during the investigation of the booster phenomenon, an increase in the identification rate of infected individuals is noticed (8, 23, 31, 32) .
Boosting of TST comprises a retesting in the absence of a new infection, an immunological recall of preexisting hypersensitivity to tuberculosis (33) . In order to evaluate the booster phenomenon, all negative patients were invited to repeat the TST after a period of one to three weeks. The occurrence of the booster phenomenon was identified when the first TST showed an induration smaller than 10 mm and the second TST presented an increase greater than 6 mm when compared with the first evaluation, with an induration of at least 10 mm (8).
Tuberculin test is a useful method in the detection of tuberculosis infection and should be performed in all HIV/AIDS patients at the time of diagnosis and annually if they present negative response. In the first test, the evaluation of the booster effect may be useful. Healthcare services must overcome the operational difficulties and offer yearly tracing to these individuals.
